Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction.
about
Reclassification of predictions for uncovering subgroup specific improvementGenetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.Recent BRCAPRO upgrades significantly improve calibration.Providing access to risk prediction tools via the HL7 XML-formatted risk web service.Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)A two-stage approach to genetic risk assessment in primary care.Underestimation of risk of a BRCA1 or BRCA2 mutation in women with high-grade serous ovarian cancer by BRCAPRO: a multi-institution study.Simplifying clinical use of the genetic risk prediction model BRCAPRO.Absence of germline BRCA1 mutations in familial pancreatic cancer patientsBRCA1/2 mutations and triple negative breast cancers.BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface.Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort.Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers.KOHBRA BRCA risk calculator (KOHCal): a model for predicting BRCA1 and BRCA2 mutations in Korean breast cancer patients.Simpson's paradox in the integrated discrimination improvement.Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO.
P2860
Q33560893-01925D01-F1CD-400B-850F-F21E498D553BQ33564013-32208413-0FBD-4637-8FCB-9AD22101B75CQ33992404-453D45F2-FF63-4926-83E9-C5CC9BBE1EBAQ34781646-B0EAFD24-8519-4456-A49F-75742DD19E5FQ35737888-45CE601F-F2ED-4CC6-B292-1E4C732D1C5CQ36547135-387A3884-A98A-4114-9A58-0CB6D2EE38F6Q36925152-011022F8-CE7F-490F-839D-24AB2804905AQ36975906-F6719972-8229-4DC7-B261-45010A4E699FQ37197715-C7CCD52F-710F-479C-9138-5B1F7F8DA71CQ37407985-C73A420B-B5A8-4917-82E9-A1119C203392Q37507410-8CB0BF84-F284-4B0E-BA7C-53198DA82375Q38131418-EEA25B3F-3A15-4645-8724-1EE2727C9355Q38262476-6BB55E93-DB35-4868-96AD-91AFCFADFC50Q40111082-C561B037-BC83-49F6-A26C-DA3CE1D1E9EAQ47436259-3181780F-2615-4BDB-B615-86223F16B1F0Q51439738-AEE65842-FABB-4153-96FC-79CDEC32897F
P2860
Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction.
@ast
Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction.
@en
type
label
Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction.
@ast
Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction.
@en
prefLabel
Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction.
@ast
Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction.
@en
P2093
P2860
P356
P1476
Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction.
@en
P2093
Alison P Klein
Giovanni Parmigiani
Sining Chen
Yu Chuan Tai
P2860
P2888
P356
10.1186/BCR1866
P577
2008-03-20T00:00:00Z
P5875
P6179
1029115431